(19)
(11) EP 0 655 918 A1

(12)

(43) Date of publication:
07.06.1995 Bulletin 1995/23

(21) Application number: 93919464.0

(22) Date of filing: 23.08.1993
(51) International Patent Classification (IPC): 
A61K( . )
A61K 9/ 14( . )
A61K 31/ 70( . )
A61P 43/ 00( . )
A61K 9/ 08( . )
A61K 31/ 195( . )
A61P 35/ 00( . )
C07F 9/ 22( . )
(86) International application number:
PCT/GB1993/001789
(87) International publication number:
WO 1994/004159 (03.03.1994 Gazette 1994/06)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 24.08.1992 GB 19920017998

(71) Applicant: THE WELLCOME FOUNDATION LIMITED
London NW1 2BP (GB)

(72) Inventors:
  • CHANDRASEKARAN, Bangaru
    Durham, NC 27707 (US)
  • DUCH, David, Stanley
    Cary, NC 27511 (US)

(74) Representative: Stott, Michael John, et al 
The Wellcome Foundation Limited Group Patents & Agreements Langley Court
Beckenham Kent BR3 3BS
Beckenham Kent BR3 3BS (GB)

   


(54) TREATMENT OF CANCER WITH AZT AND ALKYLATING OR INTERCALATING AGENTS